EU Commission: How to prepare for a "Hard Brexit"
Recommendation
26/27 June 2025
Barcelona, Spain
Supervision of the Pharmaceutical Supply Chain: Challenges and Opportunities
Register now for ECA's GMP Newsletter
If a Withdrawal Agreement between the European Union (EU) and the United Kingdom (United Kingdom, UK) is not concluded, which would create a transitional period until the end of 2020 (with the possibility of an extension provided for in the withdrawal agreement), the United Kingdom will be treated as a non-EU country (literally as a third country) from 30 March 2019 - this also applies in particular to customs provisions.
The European Commission is now fostering its support in preparing EU companies for such a no deal scenario ("Hard Brexit").
The EU Commission now reiterates that affected companies must take all steps necessary before 30 March 2019 (or before a postponed date) to avoid possible adverse effects. To support this, the European Commission has set up a "Brexit Checklist" and its website with a list of practical tips and recommendations.
Related GMP News
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review